NDC 71332-006 – Gavreto
Pralsetinib 100 mg/1 · Capsule · Oral
Product NDC71332-006
Product details
- Brand name
- Gavreto
- Generic name
- Pralsetinib
- Labeler
- Rigel Pharmaceuticals, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA213721
- Marketed since
- June 24, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Pralsetinib 100 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 71332-006-12 | 120 CAPSULE in 1 BOTTLE (71332-006-12) | Jun 24, 2024 |
| 71332-006-60 | 60 CAPSULE in 1 BOTTLE (71332-006-60) | Jun 24, 2024 |
| 71332-006-90 | 90 CAPSULE in 1 BOTTLE (71332-006-90) | Jun 24, 2024 |
Other Gavreto products
- 50242-210 Pralsetinib 100 mg/1 · Capsule · Genentech, Inc.